D.E. Shaw & Co
COCH icon

D.E. Shaw & Co’s Envoy Medical COCH Stock Holding History

D.E. Shaw & Co’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-584,288
Closed -$5.9M – 4508
2022
Q4 		$5.9M Buy
584,288
+103,788
+22% +$1.03M 0.01% 1935
2022
Q3 		$4.72M Buy
480,500
+50,000
+12% +$491K 0.01% 2161
2022
Q2 		$4.22M Hold
430,500
– – ﹤0.01% 2341
2022
Q1 		$4.21M Sell
430,500
-991,816
-70% -$9.65M ﹤0.01% 2519
2021
Q4 		$13.9M Buy
1,422,316
+1,015,000
+249% +$9.9M 0.01% 1381
2021
Q3 		$3.95M Buy
407,316
+307,316
+307% +$2.98M ﹤0.01% 2345
2021
Q2 		$970K Buy
+100,000
New +$972K ﹤0.01% 3570

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

D.E. Shaw & Co's COCH Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 584,288 shares — an estimated $5.9M sold.

D.E. Shaw & Co first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $13.9M in Q4 2021. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 584,288 Envoy Medical shares in Q1 2023, an estimated $5.9M.
  • D.E. Shaw & Co first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's Envoy Medical position peaked at $13.9M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.